DRW Securities’s Voyager Therapeutics VYGR Stock Holding History

DRW Securities’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,000	Closed	-$247K	–	475
2017 Q3	$247K	Buy	+12,000	New	+$135K	0.08%	43

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

DRW Securities's VYGR Position: Q4 2017 in Review

DRW Securities sold out of Voyager Therapeutics (VYGR) in Q4 2017, closing a stake of 12,000 shares — an estimated $247K sold.

DRW Securities first reported a position in VYGR in Q3 2017 and held it in 1 quarter. The position peaked at $247K in Q3 2017. 98 funds tracked by Wall St. Rank hold VYGR as of Q4 2017.

DRW Securities reported no remaining Voyager Therapeutics position as of Q4 2017 after selling out during the quarter.
DRW Securities sold 12,000 Voyager Therapeutics shares in Q4 2017, an estimated $247K.
DRW Securities first reported a position in Voyager Therapeutics in Q3 2017 and held it in 1 quarter.
DRW Securities's Voyager Therapeutics position peaked at $247K in Q3 2017.
98 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2017.

Based on DRW Securities's 13F filing for Q4 2017, filed 14 Feb 2018.